1. Home
  2. PHM vs ZBH Comparison

PHM vs ZBH Comparison

Compare PHM & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PulteGroup Inc.

PHM

PulteGroup Inc.

SELL

Current Price

$127.64

Market Cap

22.7B

ML Signal

SELL

Logo Zimmer Biomet Holdings Inc.

ZBH

Zimmer Biomet Holdings Inc.

N/A

Current Price

$101.50

Market Cap

18.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PHM
ZBH
Founded
1950
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.7B
18.6B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
PHM
ZBH
Price
$127.64
$101.50
Analyst Decision
Buy
Buy
Analyst Count
18
27
Target Price
★ $132.41
$116.90
AVG Volume (30 Days)
2.0M
★ 2.2M
Earning Date
10-22-2026
11-04-2026
Dividend Yield
0.82%
★ 0.93%
EPS Growth
N/A
★ N/A
EPS
★ 6.79
3.25
Revenue
N/A
★ $8,231,500,000.00
Revenue This Year
N/A
$4.65
Revenue Next Year
$0.55
$3.30
P/E Ratio
★ $18.69
$31.72
Revenue Growth
N/A
★ 7.20
52 Week Low
$107.16
$79.12
52 Week High
$144.50
$112.55

Technical Indicators

Market Signals
Indicator
PHM
ZBH
Relative Strength Index (RSI) 54.07 52.41
Support Level $112.58 $93.37
Resistance Level $133.56 $102.07
Average True Range (ATR) 4.02 3.60
MACD -0.28 -0.04
Stochastic Oscillator 43.14 38.84

Price Performance

Historical Comparison
PHM
ZBH

About PHM PulteGroup Inc.

PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Share on Social Networks: